UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Biomarkers for the early diagnosis of hepatocellular carcinoma

World journal of gastroenterology : WJG, 2015-10, Vol.21 (37), p.10573-10583

2015

Volltextzugriff (PDF)

Non–clinical efficacy, safety and stable clinical cell processing of induced pluripotent stem cell‐derived anti–glypican‐3 chimeric antigen receptor‐expressing natural killer/innate lymphoid cells

Cancer science, 2020-05, Vol.111 (5), p.1478-1490

2020

Volltextzugriff (PDF)

Blocking FSTL1 boosts NK immunity in treatment of osteosarcoma

Cancer letters, 2022-07, Vol.537, p.215690-215690, Article 215690

2022

Volltextzugriff (PDF)

Generation of hypoimmunogenic T cells from genetically engineered allogeneic human induced pluripotent stem cells

Nature biomedical engineering, 2021-05, Vol.5 (5), p.429-440

2021

Volltextzugriff (PDF)

Potentiality of immunotherapy against hepatocellular carcinoma

World journal of gastroenterology : WJG, 2015-09, Vol.21 (36), p.10314-10326

2015

Volltextzugriff (PDF)

Analysis of human glioma-associated co-inhibitory immune checkpoints in glioma microenvironment and peripheral blood

International journal of immunopathology and pharmacology, 2021-01, Vol.35, p.20587384211056505-20587384211056505

2021

Volltextzugriff (PDF)

Immune cell therapy against disseminated melanoma by utilizing induced pluripotent stem cell-derived myeloid cell lines producing interferon-beta or interleukin-15/interleukin-15 receptor alpha

Journal of dermatological science, 2021-05, Vol.102 (2), p.133-136

2021

Volltextzugriff (PDF)

Future prospects for cancer immunotherapy using induced pluripotent stem cell‐derived dendritic cells or macrophages

Experimental dermatology, 2023-03, Vol.32 (3), p.290-296

2023

Volltextzugriff (PDF)

Prospectively Isolated Human Bone Marrow Cell‐Derived MSCs Support Primitive Human CD34‐Negative Hematopoietic Stem Cells

Stem cells (Dayton, Ohio), 2015-05, Vol.33 (5), p.1554-1565

2015

Volltextzugriff (PDF)

Type I Interferon Delivery by iPSC-Derived Myeloid Cells Elicits Antitumor Immunity via XCR1+ Dendritic Cells

Cell reports (Cambridge), 2019-10, Vol.29 (1), p.162-175.e9

2019

Volltextzugriff (PDF)

Vaccination with liposome-coupled glypican-3-derived epitope peptide stimulates cytotoxic T lymphocytes and inhibits GPC3-expressing tumor growth in mice

Biochemical and biophysical research communications, 2016-01, Vol.469 (1), p.138-143

2016

Volltextzugriff (PDF)

Cellular Adjuvant Properties, Direct Cytotoxicity of Re-differentiated Vα24 Invariant NKT-like Cells from Human Induced Pluripotent Stem Cells

Stem cell reports, 2016-02, Vol.6 (2), p.213-227

2016

Volltextzugriff (PDF)

Current state and future of co-inhibitory immune checkpoints for the treatment of glioblastoma

Cancer biology & medicine, 2020-08, Vol.17 (3), p.555-568

2020

Volltextzugriff (PDF)

The level of macrophage migration inhibitory factor is negatively correlated with the efficacy of PD-1 blockade immunotherapy combined with chemotherapy as a neoadjuvant therapy for esophageal squamous cell carcinoma

Translational oncology, 2023-11, Vol.37, p.101775-101775, Article 101775

2023

Volltextzugriff (PDF)

Immunotherapy with 4-1BBL-Expressing iPS Cell-Derived Myeloid Lines Amplifies Antigen-Specific T Cell Infiltration in Advanced Melanoma

International journal of molecular sciences, 2021-02, Vol.22 (4), p.1958

2021

Volltextzugriff (PDF)

Generation of GM-CSF-producing antigen-presenting cells that induce a cytotoxic T cell-mediated antitumor response

Oncoimmunology, 2020-01, Vol.9 (1), p.1814620-1814620

2020

Volltextzugriff (PDF)

Low Level of c‐Kit Expression Marks Deeply Quiescent Murine Hematopoietic Stem Cells

Stem cells (Dayton, Ohio), 2011-11, Vol.29 (11), p.1783-1791

2011

Volltextzugriff (PDF)

Improved safety of induced pluripotent stem cell-derived antigen-presenting cell-based cancer immunotherapy

Molecular therapy. Methods & clinical development, 2021-06, Vol.21, p.171-179

2021

Volltextzugriff (PDF)

Identification and Characterization of Lineage(-)CD45(-)Sca-1(+) VSEL Phenotypic Cells Residing in Adult Mouse Bone Tissue

Stem cells and development, 2016-01, Vol.25 (1), p.27-42

2016

Volltextzugriff (PDF)

Mouse Dental Pulp Stem Cells Support Human Umbilical Cord Blood-Derived Hematopoietic Stem/Progenitor Cells in Vitro

Cell transplantation, 2015-01, Vol.24 (1), p.97-113

2015

Volltextzugriff (PDF)

Generation of mouse pluripotent stem cell-derived proliferating myeloid cells as an unlimited source of functional antigen-presenting cells

Cancer immunology research, 2015-06, Vol.3 (6), p.668-677

2015

Volltextzugriff (PDF)

Role of human non-invariant NKT lymphocytes in the maintenance of type 2 T helper environment during pregnancy

International immunology, 2008-03, Vol.20 (3), p.405-412

2008

Volltextzugriff (PDF)

Development of a high-resolution purification method for precise functional characterization of primitive human cord blood–derived CD34–negative SCID-repopulating cells

Experimental hematology, 2011-02, Vol.39 (2), p.203-213.e1

2011

Volltextzugriff (PDF)

Enhancement of antitumor effect by peptide vaccine therapy in combination with anti-CD4 antibody: Study in a murine model

Biochemistry and biophysics reports, 2016-03, Vol.5 (C), p.482-491

2016

Volltextzugriff (PDF)

Cytokine-Dependent Modification of IL-12p70 and IL-23 Balance in Dendritic Cells by Ligand Activation of Vα24 Invariant NKT Cells

The Journal of immunology (1950), 2009-07, Vol.183 (1), p.201-208

2009

Volltextzugriff (PDF)

1 – 25 von 684

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(538)
Mit Volltextzugriff
(601)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Biomarkers for the early diagnosis of hepatocellular carcinoma

Non–clinical efficacy, safety and stable clinical cell processing of induced pluripotent stem cell‐derived anti–glypican‐3 chimeric antigen receptor‐expressing natural killer/innate lymphoid cells

Blocking FSTL1 boosts NK immunity in treatment of osteosarcoma

Generation of hypoimmunogenic T cells from genetically engineered allogeneic human induced pluripotent stem cells

Potentiality of immunotherapy against hepatocellular carcinoma

Analysis of human glioma-associated co-inhibitory immune checkpoints in glioma microenvironment and peripheral blood

Immune cell therapy against disseminated melanoma by utilizing induced pluripotent stem cell-derived myeloid cell lines producing interferon-beta or interleukin-15/interleukin-15 receptor alpha

Future prospects for cancer immunotherapy using induced pluripotent stem cell‐derived dendritic cells or macrophages

Prospectively Isolated Human Bone Marrow Cell‐Derived MSCs Support Primitive Human CD34‐Negative Hematopoietic Stem Cells

Type I Interferon Delivery by iPSC-Derived Myeloid Cells Elicits Antitumor Immunity via XCR1+ Dendritic Cells

Vaccination with liposome-coupled glypican-3-derived epitope peptide stimulates cytotoxic T lymphocytes and inhibits GPC3-expressing tumor growth in mice

Cellular Adjuvant Properties, Direct Cytotoxicity of Re-differentiated Vα24 Invariant NKT-like Cells from Human Induced Pluripotent Stem Cells

Current state and future of co-inhibitory immune checkpoints for the treatment of glioblastoma

The level of macrophage migration inhibitory factor is negatively correlated with the efficacy of PD-1 blockade immunotherapy combined with chemotherapy as a neoadjuvant therapy for esophageal squamous cell carcinoma

Immunotherapy with 4-1BBL-Expressing iPS Cell-Derived Myeloid Lines Amplifies Antigen-Specific T Cell Infiltration in Advanced Melanoma

Generation of GM-CSF-producing antigen-presenting cells that induce a cytotoxic T cell-mediated antitumor response

Low Level of c‐Kit Expression Marks Deeply Quiescent Murine Hematopoietic Stem Cells

Improved safety of induced pluripotent stem cell-derived antigen-presenting cell-based cancer immunotherapy

Identification and Characterization of Lineage(-)CD45(-)Sca-1(+) VSEL Phenotypic Cells Residing in Adult Mouse Bone Tissue

Mouse Dental Pulp Stem Cells Support Human Umbilical Cord Blood-Derived Hematopoietic Stem/Progenitor Cells in Vitro

Generation of mouse pluripotent stem cell-derived proliferating myeloid cells as an unlimited source of functional antigen-presenting cells

Role of human non-invariant NKT lymphocytes in the maintenance of type 2 T helper environment during pregnancy

Development of a high-resolution purification method for precise functional characterization of primitive human cord blood–derived CD34–negative SCID-repopulating cells

Enhancement of antitumor effect by peptide vaccine therapy in combination with anti-CD4 antibody: Study in a murine model

Cytokine-Dependent Modification of IL-12p70 and IL-23 Balance in Dendritic Cells by Ligand Activation of Vα24 Invariant NKT Cells

Suchergebnisse filtern